Lidia C Sambucetti

Sri International

$3,721,361

Attributed

$5,396,303

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.1M · FY2011–19

$2M$1.5M$1M$500K$0

'11

'12

'13

'14

'15

'16

'17

'18

'19

Funding mix

By agency

NIH$5,396,303 · 6

By mechanism

R01$3,474,504 · 2

S10$826,538 · 1

N01$647,404 · 2

R21$447,857 · 1

Top collaborators

Una T O'Doherty6 shared
Subarna Sinha1 shared

Most similar at Sri International

Same institution · by research overlap

Peter B Madrid$3,303,382
Kenneth Lopez$500,000
Nathalie Scholler$712,240
Subarna Sinha$205,424
Xiaohe Liu$979,575

Others in their field

Top investigators on “Targeted Treatment”

Sonia M Thomas · Research Triangle Institute$701,865,642
Tracy L Nolen · Research Triangle Institute$474,487,152
David Heimbrook · Leidos Biomedical Research, Inc.$330,005,266
Judith S. Currier · University Of California Los Angeles$272,870,456
Peter C Adamson · National Childhood Cancer Foundation$268,343,924
Joseph J. Eron · Univ Of North Carolina Chapel Hill$172,705,574

Research focus

Targeted TreatmentIn VivoProteinsResponseDetectionDoseEvaluationCancer CellHigh Throughput ScreeningMalignant NeoplasmsCellsMutateTherapy DesignDown-RegulationLettersDisabled PersonsDrug DesignKineticsCollaborationsHigh Throughput TechnologyGag Gene ProductsCharacteristicsCd4 Positive T LymphocytesFiber Optics